Dutasteride/Tamsulosin Hydrochloride

度他雄胺/盐酸坦洛新

Report date: 2025/12/03 10:09:56

Base Information

Drug NameDutasteride/Tamsulosin Hydrochloride
Drug Alias NameDutasteride/tamsulosin盐酸坦洛新/度他雄胺度他雄胺/盐酸坦索罗辛Tamsulosin Hydrochloride/DutasterideJalyn
ClassificationSmall molecules > Steroids
Mechanisms of ActionAlpha-1a adrenergic receptor antagonistsSteroid 5 alpha reductase inhibitors
TargetsSteroid 5 alpha reductaseAlpha-1a adrenergic receptor
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsProstatic Hyperplasia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited StatesSwitzerland
Original Approved Date2010/06/14
Country/TerritoryCzechiaBelgiumBulgaria +[39] 
CombinationsYes Tamsulosin HydrochlorideDutasteride
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHanmi Pharmaceutical Co LtdGlaxosmithkline Biologicals SA
China Registration ClassN/A

Develop Information

Active CompaniesWaylis Therapeutics LLCKunming Jida Pharmaceutical Co Ltd
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeG04CA52
Related LinksWikipedia